NCT01880931

The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation in Normotensive and Hypertensive Patients

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 44 (actual)
• Sponsor: Severance Hospital · Academic / Other
• Sex: Female
• Age: 50 Years
• Healthy volunteers: Not accepted

Summary

To find out the effect site concentration of remifentanil for preventing QTc interval prolongation during intubation under propofol-remifentanil anesthesia in normotensive and hypertensive patients

Detailed description

It is known that anesthetic agents can influence the QTc. In addition, tracheal intubation during induction can stimulates sympathetic activity, which, as a results, prolong the QTc interval. Therefore, the aim of study is to find out the effect site concentration of remifentanil for preventing QTc interval prolongation during intubation under propofol-remifentanil anesthesia in normotensive and hypertensive patients.

Conditions

• Intubation, Intratracheal

Interventions

Type	Name	Description
DRUG	Remifentanil	The effect site concentration of remifentanil

Timeline

• Start date: 2013-06-01
• Primary completion: 2014-11-01
• Completion: 2014-11-01
• First posted: 2013-06-19
• Last updated: 2015-04-09

Locations

1 site across 1 country: South Korea